Adari Cell Science
Private Company
Funding information not available
Overview
Adari Cell Science is a specialized provider of cell-based assay kits focused on accelerating preclinical drug development, particularly in transporter studies critical for ADME and safety assessment. Its core value proposition lies in offering standardized, ready-to-use kits that reduce laboratory setup time and variability, enabled by a patented shipping medium from its partner ReadyCell that ensures room-temperature stability. The company targets biopharmaceutical companies and research institutions across the U.S. and Canada, positioning itself as a tools and services provider within the broader cell therapy and regenerative medicine supply chain. With an experienced leadership team and a clear partnership-driven model, Adari aims to capitalize on the growing demand for reliable, human-relevant in vitro testing models.
Technology Platform
Distributor of ready-to-use cell-based assay kits featuring patented room-temperature shipping medium and pre-cultured cells overexpressing key human drug transporters (e.g., MDR1, BCRP, MATE1) for ADME and permeability testing.
Opportunities
Risk Factors
Competitive Landscape
Adari competes in the preclinical assay market against large, diversified life science tools giants (e.g., Thermo Fisher, MilliporeSigma) and specialized CROs/service providers. Its primary differentiation is the combination of ready-to-use convenience and unique room-temperature shipping stability via its partnership, but it lacks the broad product portfolios and extensive sales forces of its larger competitors.